Skip to main content

AC Immune SA

ACIU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001651625

No open-market purchases or sales by AC Immune SA insiders were filed in the last 90 days; 43 institutions reported holding it in 13F filings for Q2 2026, worth $58.2M in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding AC Immune SA changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of ACIU: Q4 2024 compared with Q1 2025
MeasureQ4 2024Q1 2025Change
Holders4541−4
Shares27.4M25.9M−1.45M (−5.3%)
Value$73.9M$48.5M−$25.4M (−34.4%)

New holders (5)

Institutions that held AC Immune SA at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to ACIU in Q1 2025
InstitutionSharesValue% of portfolio
Eversept Partners, LP100,752$188.4K0.02%
Banque Cantonale Vaudoise26,712$50.0K0.00%
SEI Investments Co24,897$46.6K0.00%
State of Tennessee, Treasury Department5,126$9.59K0.00%
Simplex Trading, LLC284$00.00%

Sold out (9)

Institutions that held AC Immune SA at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of ACIU in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Redmile Group, LLC1,034,299$2.79M
Two Sigma Investments, LP40,818$110.2K
Jane Street Group, LLC24,283$65.6K
Rpo LLC18,728$50.6K
State of Wyoming18,219$49.2K
Boothbay Fund Management, LLC14,046$37.9K
Cubist Systematic Strategies, LLC11,667$31.5K
Compagnie Lombard Odier SCmA10,000$27.0K
Zurcher Kantonalbank (Zurich Cantonalbank)3,123$8.43K